Press Releases
Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus...
Abbott announced that the U.S. FDA has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus...
Press Releases
Bora strengthens business development team to support US growth
Bora Pharmaceuticals, a full-service contract development and manufacturing organization (CDMO) which specializes in immediate and modified release oral solids and packaging, has announced the appointment...
Drug Research
Destroying DNA to Save the Genome – Study Offers...
Sepsis is a life-threatening condition that kills millions annually; it is poorly understood and has no specific treatment. Now, researchers from Tata Memorial Centre, India,...
Drug Research
C2 PHARMA Opens Government and Research Access to Safety...
C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks of...
Press Releases
FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19...
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced that the U.S. FDA has provided Emergency Use Authorization (EUA) for the...
Press Releases
Vir Biotechnology Proceeding with Two Clinical Development Candidates for...
Vir Biotechnology, Inc announced that it has identified multiple human monoclonal antibody (mAb) development candidates that neutralize SARS-CoV-2, the virus responsible for COVID-19.
“We are pleased...
Press Releases
Positive update on the development of new XF-platform drug...
Destiny Pharma , a clinical stage biotechnology company focused on the development of novel, hospital infection prevention treatments that address the global challenge of antimicrobial...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.